ticagrelor

Improved efficacy and also increased bleeding with Rivaroxaban in Acute Myocardial Infarction

Original title:&nbsp;Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction. Results From the ATLAS ACS-2&ndash;TIMI-51 Trial. Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome Thrombolysis In Myocardial Infarction-51.&nbsp;Reference:&nbsp;Jessica L. Mega et al. J Am Coll Cardiol 2013;61:1853&ndash;9. Morbidity and mortality rates following AMI have progressively<a href="https://solaci.org/en/2013/05/07/n-2703/" title="Read more" >...</a>

Renal failure in acute myocardial infarction

Reference:&nbsp;Fox y colaboradores. Short-term Outcomes of Acute Myocardial Infarction in Patients with Acute Kidney Injury: A Report from the National Cardiovascular Data Registry. Circulation 2012 (in press). The presence of chronic renal failure is common in patients referred for angioplasty. Its presence is associated with increased mortality and bleeding. However, the prevalence is unknown as<a href="https://solaci.org/en/2012/09/01/n-3949/" title="Read more" >...</a>

Top